JPRN-UMIN000026986尚未招募未知
Phase 2 trial of utility and safety for bevacizumab in combination with adjuvant chemotherapy in cervical cancer - Trial of adjuvant chemotherapy with bevacizumab in cervical cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Patients have severe fever. 2)Patients have a hystory acute myocardial infarction. 3)Patients have ileus symptom. 4)Patients have poor control of DM and HT and VTE.
研究者
相似试验
进行中（未招募）
1 期
Clinical trial exploring the sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma.Recurrent glioblastomaMedDRA version: 15.1Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-023218-30-ITEORTC249
进行中（未招募）
不适用
Phase II randomized study of intravenous bevacizumab with sequential versus concurrent oral vinorelbine plus capecitabine in patients with locally advanced or recurrent breast cancer with lymphangitic spread to the chest wall. - NDlocally advanced or recurrent breast cancer with lymphangitic spread to the chest wall.MedDRA version: 9.1Level: LLTClassification code 10006279Term: Breast neoplasmEUCTR2006-002152-16-ITISTITUTO EUROPEO DI ONCOLOGIA
进行中（未招募）
不适用
Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell carcinomaEUCTR2007-006611-23-LTF. Hoffmann-La Roche Ltd140
进行中（未招募）
不适用
Open-label, single-arm, phase II study of bevacizumab (AVASTIN®)in combination with low-dose interferon as first-line treatment ofnephrectomised patients with metastatic clear cell renal cell carcinoma - BEVLiEUCTR2007-006611-23-DEF. Hoffmann-La Roche Ltd140
进行中（未招募）
1 期
Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell carcinoma - BEVLIMetastatic renal cell carcinomaMedDRA version: 9.1 Level: LLT Classification code 10050513 Term: Metastatic renal cell carcinomaEUCTR2007-006611-23-GBF. Hoffmann-La Roche Ltd140